Molbio Diagnostics IPO Day 2 Live: Total subscribed 3.06x; NII sHNI books 6.88x

Molbio Diagnostics IPO is now subscribed 3.06 times on Day 2 of the issue. The Non-Institutional Buyers (sHNI) category has shown the strongest interest so far, booking a subscription of 6.88 times. The issue remains open for subscription with significant participation from retail and employee investors as well.

Subscription Status

The IPO saw varied interest across different investor categories on Day 2. Here is the cumulative subscription status:

Category	Subscription Multiple
Qualified Institutional Buyers (QIB)	1.39 x
Non-Institutional Buyers (bHNI)	4.2 x
Non-Institutional Buyers (sHNI)	6.88 x
Retail	3.14 x
Employees	4.74 x
Total Subscribed	3.06 x

About the Company

Molbio Diagnostics is a key player in the diagnostics sector. The company offers a range of diagnostic solutions and services. The IPO aims to raise capital for business expansion and other corporate purposes. The issue size ranges from ₹13,158 to ₹500,000, indicating the scale of the offering.

Key Dates

The IPO is currently in its subscription phase. Investors can apply until the issue closes. The price band for the IPO is set between ₹768 and ₹807. The minimum bid quantity is 18 units.

Offer Details

Floor Price: ₹768.00000
Ceiling Price: ₹807.00000
Min Bid Qty: 18
Min IPO Size: ₹13,158
Max IPO Size: ₹500,000

Investors are advised to review the final prospectus before applying. The allotment and listing dates will be announced after the closure of the issue.

Molbio Diagnostics IPO opened for subscription today, witnessing an overall subscription of 0.81x on Day 1. The Qualified Institutional Buyers (QIB) category led the demand with a 1x subscription, while the Non-Institutional Individual (NII) and Retail categories saw lower participation.

Subscription Status

On the first day of the issue, the subscription numbers were as follows:

Category	Subscription Multiple
Qualified Institutional Buyers (QIB)	1 x
Employees	2.1 x
Retail	0.73 x
Non-Institutional Buyers (bHNI)	0.67 x
Non-Institutional Buyers (sHNI)	0.74 x
Total Subscribed	0.81 x

About the Company

Molbio Diagnostics is a prominent player in the diagnostics sector. The company has filed its IPO to raise capital through this public offering. Key financial metrics and operational details are outlined in the prospectus filed with regulatory authorities.

Offer Details

The issue is priced between ₹768 and ₹807 per share. The minimum bid quantity is set at 18 shares. The IPO size ranges from ₹13,158 crore to ₹5,00,000 crore as per the provided data parameters.